235 related articles for article (PubMed ID: 16485342)
1. Insomnia market.
Gershell L
Nat Rev Drug Discov; 2006 Jan; 5(1):15-6. PubMed ID: 16485342
[No Abstract] [Full Text] [Related]
2. The risks of pharmacological therapy for insomnia (part 1): update for the clinical nurse specialist.
O'Malley P
Clin Nurse Spec; 2007; 21(4):188-90. PubMed ID: 17622806
[No Abstract] [Full Text] [Related]
3. Insomnia.
Holzinger E
IDrugs; 2005 May; 8(5):410-5. PubMed ID: 15883924
[TBL] [Abstract][Full Text] [Related]
4. Treatment of insomnia.
Treat Guidel Med Lett; 2006 Feb; 4(42):5-10. PubMed ID: 16467736
[No Abstract] [Full Text] [Related]
5. Brotizolam in the treatment of insomnia.
Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
Psychopharmacol Bull; 1985; 21(1):97-100. PubMed ID: 3885295
[No Abstract] [Full Text] [Related]
6. Insomnia: costs to lose sleep over.
Smith MD; McGhan WF
Bus Health; 1997 Jun; 15(6):57-8, 60. PubMed ID: 10168151
[No Abstract] [Full Text] [Related]
7. Eszopiclone (Lunesta) for treatment of transient and chronic insomnia.
Wessell AM; Weart CW
Am Fam Physician; 2005 Jun; 71(12):2359-60. PubMed ID: 15999875
[No Abstract] [Full Text] [Related]
8. Sleeping pills: are they worth the risk?
Consum Rep; 2006 Sep; 71(9):48-9. PubMed ID: 16929577
[No Abstract] [Full Text] [Related]
9. [Evaluation of the hypnotic properties of nitrazepam (Mogadon) in insomnia in mental patients].
Tétreault L; Huot J; Bordeleau JM
Union Med Can; 1966 Dec; 95(12):1392-400. PubMed ID: 4870760
[No Abstract] [Full Text] [Related]
10. A new era in drug regulation?
Dresser R
Hastings Cent Rep; 2005; 35(3):10-1. PubMed ID: 16092391
[No Abstract] [Full Text] [Related]
11. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
Jhaveri M; Seal B; Pollack M; Wertz D
Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
[TBL] [Abstract][Full Text] [Related]
12. Placebo effects in primary insomnia.
Perlis ML; McCall WV; Jungquist CR; Pigeon WR; Matteson SE
Sleep Med Rev; 2005 Oct; 9(5):381-9. PubMed ID: 16109495
[TBL] [Abstract][Full Text] [Related]
13. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Najib J
Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
[TBL] [Abstract][Full Text] [Related]
14. [Insomnia].
Doerr JP; Voderholzer U
Med Monatsschr Pharm; 2008 Sep; 31(9):339-45. PubMed ID: 18831465
[TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of two hypnotic agents in genral practice patients with insomnia.
Rickels K; Rosenfeld H; Schneider B; Silverman HA; Wagner IG
Curr Ther Res Clin Exp; 1972 Jun; 14(6):293-7. PubMed ID: 4625800
[No Abstract] [Full Text] [Related]
16. Drugs for insomnia.
Hartmann E
Ration Drug Ther; 1977 Dec; 11(12):1-6. PubMed ID: 594363
[No Abstract] [Full Text] [Related]
17. Hypnotic drugs and treatment of insomnia.
Conn Med; 1980 Oct; 44(10):651-3. PubMed ID: 7226767
[No Abstract] [Full Text] [Related]
18. [Care and treatment of insomnia].
Syvälahti E
Duodecim; 2005; 121(18):1950-1. PubMed ID: 16300308
[No Abstract] [Full Text] [Related]
19. Indiplon: the development of a novel therapy for the treatment of sleep onset and sleep maintenance insomnia.
Lankford A; Ancoli-Israel S
Int J Clin Pract; 2007 Jun; 61(6):1037-45. PubMed ID: 17386060
[TBL] [Abstract][Full Text] [Related]
20. The report by the Institute of Medicine and postmarketing surveillance.
Klein DF
Arch Gen Psychiatry; 1999 Apr; 56(4):353-4. PubMed ID: 10197831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
